
CIK 0001735438
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 16 | Giroux RichardCFO & COO | Open-market sale · 10b5-1 plan | SELL | $557K 56.0K sh | Oct 20, 2026 traded Oct 20, 2026 | |
Naylor StuartCHIEF SCI OFCR, OPHTHALMOLOGY |
Open-market sale · 10b5-1 plan |
| SELL |
| $294K 27.7K sh |
| Oct 6, 2026 traded Oct 6, 2026 |
| 7 | Naylor StuartCHIEF SCI OFCR, OPHTHALMOLOGY | Open-market sale · 10b5-1 plan | SELL | $374K 25.1K sh | Jul 7, 2026 traded Jul 7, 2026 |
| 1 | Naylor StuartCHIEF SCI OFCR, OPHTHALMOLOGY | Open-market sale · 10b5-1 plan | SELL | $35K 2,547 sh | Jul 7, 2026 traded Jul 7, 2026 |
| 9 | Zeldin Robert KCHIEF MEDICAL OFFICER | Grant or award | A | — 100.0K sh | Jun 29, 2026 traded Jun 25, 2026 |
| 9 | Wollin Robert JGENERAL COUNSEL AND SECRETARY | Grant or award | A | — 100.0K sh | Jun 29, 2026 traded Jun 25, 2026 |
| 9 | Forbes AlexandriaDirector, PRESIDENT & CEO | Grant or award | A | — 980.0K sh | Jun 29, 2026 traded Jun 25, 2026 |
| 5 | Giroux RichardCFO & COO | Grant or award | A | — 980.0K sh | Jun 29, 2026 traded Jun 25, 2026 |
| 5 | Naylor StuartCHIEF SCI OFCR, OPHTHALMOLOGY | Grant or award | A | — 70.0K sh | Jun 29, 2026 traded Jun 25, 2026 |
| 9 | Yu DebraDirector | Grant or award | A | — 60.0K sh | Jun 15, 2026 traded Jun 11, 2026 |
| 21 | Harris Keith R.Director | Option exercise | M | — 75.0K sh | Jun 10, 2026 traded Jun 10, 2026 |
| 9 | Harris Keith R.Director | Option exercise | M | — 75.0K sh | Jun 10, 2026 traded Jun 10, 2026 |
| 9 | Fleck Penny ReneeCHIEF DEVELOPMENT OFFICER | Grant or award | A | — 100.0K sh | May 14, 2026 traded May 13, 2026 |
| 9 | Fleck Penny ReneeCHIEF DEVELOPMENT OFFICER | Grant or award | A | — 100.0K sh | May 14, 2026 traded May 13, 2026 |
| 20 | Giroux RichardCFO & COO | Open-market sale · 10b5-1 plan | SELL | $572K 56.0K sh | Apr 21, 2026 traded Apr 21, 2026 |
| 16 | Naylor StuartCHIEF DEV. OFFICER | Open-market sale · 10b5-1 plan | SELL | $259K 27.7K sh | Apr 7, 2026 traded Apr 7, 2026 |
| 27 | Wollin Robert JGENERAL COUNSEL AND SECRETARY | Option exercise | M | — 50.0K sh | Jan 21, 2026 traded Jan 17, 2026 |
| 15 | Wollin Robert JGENERAL COUNSEL AND SECRETARY | Option exercise | M | — 50.0K sh | Jan 21, 2026 traded Jan 17, 2026 |
| 30 | Wollin Robert JGENERAL COUNSEL AND SECRETARY | Tax withholding | F | $202K 27.2K sh | Jan 21, 2026 traded Jan 17, 2026 |
| 13 | Zeldin Robert KCHIEF MEDICAL OFFICER | Option exercise | M | — 17.5K sh | Jan 8, 2026 traded Jan 7, 2026 |
| 9 | Wollin Robert JGENERAL COUNSEL AND SECRETARY | Option exercise | M | — 7,500 sh | Jan 8, 2026 traded Jan 7, 2026 |
| 17 | Wollin Robert JGENERAL COUNSEL AND SECRETARY | Option exercise | M | — 7,500 sh | Jan 8, 2026 traded Jan 7, 2026 |
| 13 | Wollin Robert JGENERAL COUNSEL AND SECRETARY | Tax withholding | F | $34K 4,364 sh | Jan 8, 2026 traded Jan 7, 2026 |
| 12 | Giroux RichardCFO & COO | Tax withholding | F | $223K 28.8K sh | Jan 8, 2026 traded Jan 7, 2026 |
| 13 | Giroux RichardCFO & COO | Option exercise | M | — 52.5K sh | Jan 8, 2026 traded Jan 7, 2026 |
| 9 | Giroux RichardCFO & COO | Option exercise | M | — 52.5K sh | Jan 8, 2026 traded Jan 7, 2026 |
| 9 | Naylor StuartCHIEF DEV. OFFICER | Option exercise | M | — 37.5K sh | Jan 8, 2026 traded Jan 7, 2026 |
| 13 | Naylor StuartCHIEF DEV. OFFICER | Option exercise | M | — 37.5K sh | Jan 8, 2026 traded Jan 7, 2026 |
| 12 | Naylor StuartCHIEF DEV. OFFICER | Tax withholding | F | $136K 17.6K sh | Jan 8, 2026 traded Jan 7, 2026 |
| 9 | Zeldin Robert KCHIEF MEDICAL OFFICER | Option exercise | M | — 17.5K sh | Jan 8, 2026 traded Jan 7, 2026 |
| 12 | Zeldin Robert KCHIEF MEDICAL OFFICER | Tax withholding | F | $52K 6,729 sh | Jan 8, 2026 traded Jan 7, 2026 |